Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

same period in 2010.

Conference Call Amylin will webcast its Quarterly Update and Year End Conference Call today at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. During the call, the Company plans to provide further details underlying its fourth quarter and full year 2011 financial results. A slide presentation accompanying the conference call is available through the "Investors" section of Amylin's corporate website at www.amylin.com.

To access the webcast, please log on to www.amylin.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (800) 857-5738 (U.S./Canada) or (415) 228-4970 (international), participant passcode number 7253303. A replay of the call will also be available by phone beginning approximately two hours after the close of the call and can be accessed at (866) 673-3565 (U.S./Canada) or (402) 220-6428 (international).

Note Regarding Use of Non-GAAP Financial Measures Amylin reports non-GAAP operating income/(loss), non-GAAP net income/(loss) and non-GAAP net income/(loss) per share adjusted for non-cash items and other items such as restructuring charges and charges and credits relating to the reacquisition of exenatide product rights (including amortization and interest expense relating to reacquired assets, fair value adjustments and revenue sharing obligations), which are non-GAAP financial measures. The Company believes that investors' understanding of its progress towards its stated goal of generating sustainable positive non-GAAP operating results is enhanced by this disclosure. In addition, the Company refers to this non-GAAP financial information with its analysis of the Company's financial performance. These non-GAAP fin
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
(Date:7/30/2015)... Inc. (NYSE: RMD ) today announced results for ... quarter was $453.1 million, a 9 percent increase compared ... percent increase on a constant currency basis).  Net income ... 30, 2014.  Diluted earnings per share for the quarter ... 2014.  The results for the quarter ...
(Date:7/30/2015)... VANCOUVER , July 30, 2015  OncoGenex ... it will report its second quarter 2015 financial results ... a conference call and live webcast at 4:30 p.m. ... clinical development programs and a general corporate update. ... the Investor Relations page of the OncoGenex website at ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... Corporation,(Nasdaq: IOMI ) today announced that interim results ... patch-based vaccine for travelers, diarrhea,found that all subjects who ... -- mounted an immune response, demonstrating that even elderly,subjects ... The trial was designed to compare the number of ...
... N.C., Aug. 10 More than 33% ... identify clinical,investigators 50% faster than their industry ... clinical trial costs while improving quality,by employing ... to research probing clinical trial excellence by,pharmaceutical ...
Cached Medicine Technology:Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine 2Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine 3Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine 4Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management 2
(Date:8/1/2015)... ... 02, 2015 , ... Back packs can be dangerous? Whaaat?! , Not the ... wreck havoc on a kid's spine. With school starting again, most kids will be ... sure you are aware of how to help them prevent injuries by understanding backpack ...
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins ... men and women often causing pain and discomfort. Those who spend a lot of ... and Northeast Houston Vein Center is doing what it can to create awareness and ...
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the ... of their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has ... both companies have agreed to join their missions of purpose together to change the ...
(Date:8/1/2015)... ... ... Lume Wellness creators Alex, Robert, and Sam have announced update 3.0.1 to ... , The app is designed to track various metrics of wellness, including physical activity, ... health and use this information for positive behavior modification. Lume Wellness keeps track of ...
(Date:8/1/2015)... ... ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction ... stepping off Springer Mountain and heading north. Since that day, Phil has hiked over 1400 ... greeted by friends and family. He visited CCAR and left an inspirational message to ...
Breaking Medicine News(10 mins):Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
... ... ... ... ...
... ... ... , ... ...
... ... ... ... ...
... shown to be effective in breast cancer packs an effective ... a specific genetic mutation, a study at UCLA,s Jonsson Comprehensive ... when given together proved to significantly inhibit tumor growth in ... mutation that results in an aggressive form of the disease, ...
... scientists studying acute forms of Leukaemia have identified a new ... the growth of diseased cells. The research, reported in ... to genes, which if targeted could prevent diseased cells from ... the University of Vienna, carried out their research on acute ...
... bone mineral density, strength and postural balance due to ... group of women but also for elderly men, says ... and continues "It is well known that the risk ... result of weaker bones, poorer balance and attenuated ability ...
Cached Medicine News:Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 4Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 5Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 2Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 3Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 4Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 5Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 7Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 8Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 9Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 10Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 11Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 12Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 13Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 14Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 15Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 16Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 17Health News:Marketech Celebrates 25 Years of Service 2Health News:Marketech Celebrates 25 Years of Service 3Health News:Marketech Celebrates 25 Years of Service 4Health News:Marketech Celebrates 25 Years of Service 5Health News:Herceptin and Tykerb effective against a subset of gastric cancers 2Health News:Herceptin and Tykerb effective against a subset of gastric cancers 3Health News:Targeting leukemia cell's gene 'addiction' presents new strategy for treatment 2Health News:Soccer reduces risk of falls and bone fractures 2Health News:Soccer reduces risk of falls and bone fractures 3
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
Malaria device / strip (3 line, P.f/P.v Ag Test-pLDH)...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Medicine Products: